Your browser doesn't support javascript.
loading
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
Galesloot, Tessel E; Grotenhuis, Anne J; Kolev, Dimitar; Aben, Katja K; Bryan, Richard T; Catto, James W F; Cheng, Kar K; Conroy, Samantha; Dyrskjøt, Lars; Fleshner, Neil E; James, Nicholas D; Lamy, Philippe; Lindskrog, Sia Viborg; Malats, Núria; Mengual, Lourdes; Verhaegh, Gerald; Zeegers, Maurice P; Kiemeney, Lambertus A L M; Vermeulen, Sita H.
Afiliação
  • Galesloot TE; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands. Electronic address: Tessel.Galesloot@radboudumc.nl.
  • Grotenhuis AJ; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.
  • Kolev D; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.
  • Aben KK; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Bryan RT; Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK; Bladder Cancer Research Centre, University of Birmingham, Birmingham, UK.
  • Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Cheng KK; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Conroy S; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Fleshner NE; Department of Urology, Princess Margaret Cancer Centre, Toronto, Canada.
  • James ND; Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain; CIBERONC, Madrid, Spain.
  • Mengual L; Department and Laboratory of Urology, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Verhaegh G; Department of Urology, Radboud university medical center, Nijmegen, The Netherlands.
  • Zeegers MP; Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Complex Genetics and Epidemiology, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands; CAPHRI School for Public Health and Primary Care, U
  • Kiemeney LALM; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands; Department of Urology, Radboud university medical center, Nijmegen, The Netherlands.
  • Vermeulen SH; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.
Eur Urol Oncol ; 5(1): 70-83, 2022 02.
Article em En | MEDLINE | ID: mdl-34353775
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article